DE3047142

The invention relates to novel basic ethers of the general formula /I/ and pharmaceutically acceptable acid addition salts and quaternary salts thereof, /I/ wherein R1 and R2 may be the same or different and represent a C1-5 alkyl group or a C3-6 cycloalkyl group or they form, together with the adja...

Full description

Saved in:
Bibliographic Details
Main Authors LAY, GEB. KONYA, ARANKA, PETOECZ, LUJZA, GRASSER, KATALIN, MAGDANYI, LASZLO, BUDAI, ZOLTAN, MEZEI, TIBOR, KOSOCZKY, IBOLYA., BUDAPEST, HU
Format Patent
LanguageEnglish
Published 26.09.1985
Edition4
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to novel basic ethers of the general formula /I/ and pharmaceutically acceptable acid addition salts and quaternary salts thereof, /I/ wherein R1 and R2 may be the same or different and represent a C1-5 alkyl group or a C3-6 cycloalkyl group or they form, together with the adjacent nitrogen atom, a heterocyclic ring containing 4-7 carbon atoms and optionally a further hetero atom, e.g. an oxygen, sulfur or nitrogen atom, and this latter may be optionally substituted by a C1-3 alkyl, benzyl or phenyl group, R represents a phenyl, phenyl-/C1-3 alkyl/ or thienyl group optionally substituted by one or more halogen or C1-3 alkoxy substituent/s/, A represents a C2-5 straight or branched alkylene chain, and represents a valence bond of alpha or beta configuration. The new compounds of the general formula /I/ possess valuable anticonvulsive, motility inhibiting, hexobarbital narcose potentiating and analgesic effects, which are, in case of certain compounds, complemented by week antiserotonine, gastro-intestinal-tract inhibiting and antiinflammatory effects, and can be applied to advantage in the therapy.
Bibliography:Application Number: DE19803047142